BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31610783)

  • 1. Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status.
    Jin JL; Cao YX; Liu HH; Zhang HW; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Sun J; Dong Q; Li JJ
    Cardiovasc Diabetol; 2019 Oct; 18(1):134. PubMed ID: 31610783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
    Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
    Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes.
    Cao YX; Zhang HW; Jin JL; Liu HH; Zhang Y; Gao Y; Guo YL; Wu NQ; Hua Q; Li YF; Li XL; Xu RX; Cui CJ; Liu G; Dong Q; Sun J; Zhu CG; Li JJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):104. PubMed ID: 32631321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study.
    Liu HH; Cao YX; Jin JL; Guo YL; Zhu CG; Wu NQ; Gao Y; Zhang Y; Xu RX; Dong Q; Li JJ
    Cardiovasc Diabetol; 2021 Apr; 20(1):84. PubMed ID: 33888145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes.
    Jin JL; Cao YX; Zhang HW; Sun D; Hua Q; Li YF; Guo YL; Wu NQ; Zhu CG; Gao Y; Dong QT; Liu HH; Dong Q; Li JJ
    Diabetes Care; 2019 Jul; 42(7):1312-1318. PubMed ID: 31076417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes.
    Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Li XL; Cui CJ; Liu G; Sun J; Dong Q; Santos R; Li JJ
    Cardiovasc Diabetol; 2020 Sep; 19(1):152. PubMed ID: 32981521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study.
    Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Wu NQ; Zhu CG; Xu RX; Gao Y; Li XL; Cui CJ; Liu G; Sun J; Dong Q; Guo YL; Li JJ
    Cardiovasc Diabetol; 2020 Apr; 19(1):45. PubMed ID: 32245386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study.
    Farhan S; Redfors B; Maehara A; McAndrew T; Ben-Yehuda O; De Bruyne B; Mehran R; Giustino G; Kirtane AJ; Serruys PW; Mintz GS; Stone GW
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):733-741. PubMed ID: 29055637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
    Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
    Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study.
    Peng J; Liu MM; Jin JL; Cao YX; Guo YL; Wu NQ; Zhu CG; Dong Q; Sun J; Xu RX; Li JJ
    Cardiovasc Diabetol; 2020 Oct; 19(1):167. PubMed ID: 33023603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic utility of heart-type fatty acid-binding protein in patients with stable coronary artery disease and impaired glucose metabolism: a cohort study.
    Zhang HW; Jin JL; Cao YX; Liu HH; Zhang Y; Guo YL; Wu NQ; Gao Y; Xu RX; Hua Q; Li YF; Cui CJ; Liu G; Dong Q; Sun J; Li JJ
    Cardiovasc Diabetol; 2020 Feb; 19(1):15. PubMed ID: 32041617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-diabetes mellitus newly diagnosed after myocardial infarction adversely affects prognosis in patients without known diabetes.
    Chattopadhyay S; George A; John J; Sathyapalan T
    Diab Vasc Dis Res; 2019 Nov; 16(6):489-497. PubMed ID: 31044609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal assessment of coronary plaque volume change related to glycemic status using serial coronary computed tomography angiography: A PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) substudy.
    Won KB; Lee SE; Lee BK; Park HB; Heo R; Rizvi A; Lin FY; Kumar A; Hadamitzky M; Kim YJ; Sung JM; Conte E; Andreini D; Pontone G; Budoff MJ; Gottlieb I; Chun EJ; Cademartiri F; Maffei E; Marques H; Leipsic JA; Shin S; Choi JH; Virmani R; Samady H; Chinnaiyan K; Raff GL; Stone PH; Berman DS; Narula J; Shaw LJ; Bax JJ; Min JK; Chang HJ
    J Cardiovasc Comput Tomogr; 2019; 13(2):142-147. PubMed ID: 30580992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Importance of Impaired Fasting Glycemia in Chronic Coronary Heart Disease Patients.
    Slezák D; Mayer O; Bruthans J; Seidlerová J; Rychecká M; Gelžinský J; Mateřánková M; Karnosová P; Wohlfahrt P; Cífková R; Filipovský J
    Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):29-35. PubMed ID: 30157533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative disturbances of glucose metabolism and mortality after coronary artery bypass grafting.
    Djupsjo C; Sartipy U; Ivert T; Karayiannides S; Lundman P; Nystrom T; Holzmann MJ; Kuhl J
    Open Heart; 2020 Jun; 7(1):. PubMed ID: 32487771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma free fatty acids levels with the presence and severity of coronary and carotid atherosclerotic plaque in patients with type 2 diabetes mellitus.
    Zhang MH; Cao YX; Wu LG; Guo N; Hou BJ; Sun LJ; Guo YL; Wu NQ; Dong Q; Li JJ
    BMC Endocr Disord; 2020 Oct; 20(1):156. PubMed ID: 33087077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.
    Schrieks IC; Nozza A; Stähli BE; Buse JB; Henry RR; Malmberg K; Neal B; Nicholls SJ; Rydén L; Mellbin L; Svensson A; Wedel H; Weichert A; Lincoff AM; Tardif JC; Grobbee DE; Schwartz GG
    Diabetes Care; 2018 Aug; 41(8):1792-1800. PubMed ID: 29903845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum free fatty acids are associated with severe coronary artery calcification, especially in diabetes: a retrospective study.
    Xin Y; Zhang J; Fan Y; Wang C
    BMC Cardiovasc Disord; 2021 Jul; 21(1):343. PubMed ID: 34266394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.
    Dauriz M; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.